Searched for
IPCA LABS SHARES
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a monthDespite a marginal rise in the Sensex, seven BSE 500 stocks touched fresh 52-week highs, signalling strong bullish momentum. Gland Pharma, ...
- Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
- Reduce Ipca Labs, target price Rs 1,250: Prabhudas LilladherIpca Labs (IPCA) Q1 EBITDA of Rs 3.9 bn was in line with our estimate. Management guidance of 9% revenue growth (excluding Unichem) was bel...
- F&O Radar | Deploy Debit Spread in Ipca Labs to play potential upward rallyIpca Laboratories' stock price traded within a range around the Rs 1,360 level during April and May. However, it subsequently trended downw...
- Ipca Labs falls 3% after USFDA issues Form 483 to API unitShares of Indian pharmaceutical company, Ipca Laboratories, fell by 3% after the US Food and Drug Administration (USFDA) issued a Form 483 ...
- Ipca Labs shares tumble 9% on acquisition of stake in Unichem LaboratoriesIpca Laboratories has agreed to buy 33.38% of the paid-up equity share capital of Unichem Laboratories for INR1,034.06 crore ($160m). The a...
- Chart Check: Ipca Laboratories gives a breakout from a falling trend line resistance; time to buy?Ipca Laboratories, a pharma company, is a potential buy as it has recorded a breakout from a falling trendline resistance and a Cup & Handl...
- Ipca Labs shares drop over 5% on weak Q3 results. What should investors do?EBITDA before forex declined 15% to Rs 262.82 crore in the third quarter of 2022 from Rs 310.83 crore posted in the same quarter of FY22. E...
- This drug maker, 40% owned by MF & FPIs, just had a weak Q2. Time to sell?The scrip has been a favourite of mutual funds and FPIs, who owned over 40 per cent stake in the drug maker, with promoters holding another...
- Ipca Labs Q1 results: Net profit declines 31% to Rs 307 croreConsolidated total income of the company stood at Rs 1,586.81 crore for the quarter under consideration.
- Ipca Labs acquires 13% stake in Trophic Wellness for Rs 21 croreThe acquisition of the shares is for cash consideration of Rs 21.20 crore for 5,30,000 equity shares of TWPL, Ipca Labs added.
- Ipca Labs Q3 results: Net profit rises 35% to Rs 267.56 croreIts consolidated total income stood at Rs 1,425.21 crore for the quarter under consideration. It was Rs 1,230.99 crore for in the year-ago ...
- Buy Ipca Labs with a target of Rs 700: Prakash Gaba'Buy Ipca Labs Ltd with a target of Rs 700 and a stop loss of Rs 670'
- Buy Ipca Labs with a target of Rs 820: Ashwani GujralIpca Labs is a 'BUY' call with a target of Rs 820 and a stop loss of Rs 640.
- Buy Ipca labs with target price of Rs 1,100: Ashwani GujralIpca labs is a 'BUY' call with a target of Rs 1,100 and a stop loss of Rs 770.
- Buy IPCA Labs Ltd with target price of Rs 576: Sandeep WagleBuy IPCA Labs Ltd at a stop of Rs 421.
- Buy IPCA Lab Ltd with target price of Rs 615: Ashwani GujralBuy IPCA Lab Ltd at a stop of Rs 580.
Load More
